Novartis's big bet on sickle cell disease struggles to reach Kenya
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.
Source: swissinfo.ch
Stay updated with breaking news from Emaculate Achieng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.
Pharma giants are pouring money into new therapies for sickle cell disease but in Kenya, patients struggle to access a decades-old drug.